Search results

After the collapse of the USSR, Eurasian integration projects, proposed by Russia, Kazakhstan and Turkey, began to develop in the post-Soviet space. Hence, there is growing interest in Eurasianism as an ideology. In this context, the study of the use of the Eurasianism's ideas in practice becomes relevant. The argument of this article is that Russia, Turkey, and Kazakstan have their own interpretations of Eurasianism's ideas to develop the ideological basis of their own integration projects. The purpose of the article is to answer the question: How is the Eurasianism used in integration projects of Russia, Turkey and Kazakstan?

The concept of Eurasianism has been viewed in terms of constructivism. On the basis of the principles of social constructivism, and in particular the works of constructivist ideologue Alexander Wendt, a comparative analysis was made. The ideas of Eurasianism in the integration processes of Russia, Kazakhstan and Turkey has been carried out based on the criteria such as the role of common ideas, identity, consciousness, memory and culture. The examples of mentioned countries were compared, to consider the development of the ideas of Eurasianism in practice.

The ideas of Eurasianism have a significant impact on the integration processes of the post-Soviet space. Eurasianism advocates for important factors such as respect for cultural and civilizational differences between different nations, their equality in the overall union and common development opportunities. Such factors are undoubtedly important for the success of integration projects. The reflection of many individual thoughts of classical Eurasians and Neo-Eurasians can be seen in the statements of various ministers and leaders of Russia, Kazakhstan and Turkey. The initiatives of these countries in creating integration projects also show the influence of the Eurasian concept.

In the 1990s, the study of Eurasianism gained new significance in academic circles. Articles and periodicals devoted to this concept were published. However, all parallels between variations in concepts of Eurasianism have been conducted on a theoretical level. The importance of this article lies in the fact that conceptual differences are compared in practice. Researchers had not previously considered the study of the relevance and productivity of Eurasianism in practice by comparing examples and experiences from different countries. The novelty of this article lies in its attempt to solve this problem.

Additive manufacturing (AM), also known as three-dimensional (3D) printing technology, has been used in the health-care industry for over two decades. It is in high demand in the health-care industry due to its strength to manufacture custom-designed and personalized 3D constructs. Recently, AM technologies are being explored to develop personalized drug delivery systems, such as personalized oral dosages, implants and others due to their potential to design and develop systems with complex geometry and programmed controlled release profile. Furthermore, in 2015, the US Food and Drug Administration approved the first AM medication, Spritam® (Apprecia Pharmaceuticals) which has led to tremendous interest in exploring this technology as a bespoke solution for patient-specific drug delivery systems. The purpose of this study is to provide a comprehensive overview of AM technologies applied to the development of personalized drug delivery systems, including an analysis of the commercial status of AM based drugs and delivery devices.

This review paper provides a detailed understanding of how AM technologies are used to develop personalized drug delivery systems. Different AM technologies and how these technologies can be chosen for a specific drug delivery system are discussed. Different types of materials used to manufacture personalized drug delivery systems are also discussed here. Furthermore, recent preclinical and clinical trials are discussed. The challenges and future perceptions of personalized medicine and the clinical use of these systems are also discussed.

Substantial works are ongoing to develop personalized medicine using AM technologies. Understanding the regulatory requirements is needed to establish this area as a point-of-care solution for patients. Furthermore, scientists, engineers and regulatory agencies need to work closely to successfully translate the research efforts to clinics.

This review paper highlights the recent efforts of AM-based technologies in the field of personalized drug delivery systems with an insight into the possible future direction.